Dna X SONM
NASDAQ SONM
$3.09 -0.22 (-6.43%)
As of: Oct 20, 2026 · 3:42 PM EDT

Dna X (SONM) Net Cash Flow (2018 - 2026)

Updated

Dna X's Net Cash Flow came in at -$403,000 for FY2026.

Analysis

Dna X (SONM) Net Cash Flow (2018 - 2026) Analysis & Trends

Going back to FY2018, Dna X's Net Cash Flow data covers 9 years.

  • The FY2026 figure represents the highest annual Net Cash Flow since FY2022.
  • Per Business Quant, earlier years put Net Cash Flow at -$4.04 million in FY2025, -$4.05 million in FY2024, -$3.82 million in FY2023 and $1.98 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Cme 106.56 Bn 94.66 Bn - -7.17 Bn
2 Intercontinental Exchange 89.45 Bn 83.19 Bn - -2.87 Bn
3 Robinhood Markets 88.18 Bn 69.22 Bn - 1.86 Bn
4 Nasdaq 53.47 Bn 50.90 Bn 1.50 Bn -318.00 Mn
5 Interactive Brokers 37.14 Bn 14.26 Bn - 5.86 Bn
6 Cboe Global Markets 33.00 Bn 24.66 Bn 731.60 Mn -721.70 Mn
7 LPL Financial Holdings 25.71 Bn 21.03 Bn - 22.80 Mn
8 Tradeweb Markets 25.33 Bn 17.34 Bn - 121.07 Mn
9 Circle Internet 21.30 Bn 15.18 Bn 288.85 Mn -3.41 Bn
10 Dna X 4.17 Mn -1.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -108,000.00
Dec 31, 2025 -834,000.00
Sep 30, 2025 131,000.00
Jun 30, 2025 -109,000.00
Mar 31, 2025 -3.23 Mn
Dec 31, 2024 -3.72 Mn
Sep 30, 2024 -540,000.00
Jun 30, 2024 348,000.00
Mar 31, 2024 -145,000.00
Dec 31, 2023 -400,000.00
Sep 30, 2023 77,000.00
Jun 30, 2023 784,000.00
Mar 31, 2023 -4.25 Mn
Dec 31, 2022 -2.26 Mn
Sep 30, 2022 -2.68 Mn
Jun 30, 2022 7.53 Mn
Mar 31, 2022 -603,000.00
Dec 31, 2021 1.05 Mn
Sep 30, 2021 3.31 Mn
Jun 30, 2021 -7.02 Mn
API Access

Dna X Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=SONM&period=max&api_key=YOUR_API_KEY